News

Technology News

AirXpanders To Launch Offering On ASX

Tuesday, May 26, 2015 5:01:00 AM PDT | VentureDeal
   Sydney, Australia  --  US medical device technology company AirXpanders has announced the launch of its initial public offering (IPO) on the Australian Securities Exchange.

The company is offering 73 million CDIs (CHESS Depositary Interests) at AU $0.50/CDI.

If fully subscribed, the fully-diluted market capitalization of the company would be approximately AU $113 million.

The company hopes to raise a total of AU $36.5 million in the offering.

AirXpanders has created tissue expander technology that is used in breast reconstruction procedures following mastectomy to expand and stretch the skin before basement of a permanent breast implant.


(Note: This article does not represent a solicitation or offer of sale of any securities. The proposed AirXpanders offering is made under a prospectus, copies of which are available at:  https://www.airxpandersipo.com/offer/)

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1